– Du Bois A., Ewald-Riegler N., De Gregorio N. et al.: Borderline tumours of the ovary: a cohort study of the Arbeitsgemeinschaft Gynäkologische Onkologie (AGO) Study Group. Eur J Cancer 2013; 49: 1905
– Gershenson D.M., Sun C.C., Bodurka D. et al.: Recurrent low-grade serous ovarian carcinoma is relatively chemoresistant. Gynecol Oncol 2009; 114: 48
– Harter P., Gershenson D., Lhomme C. et al..: Gynecologic Cancer InterGroup (GCIG) consensus review for ovarian tumors of low malignant potential (borderline ovarian tumors). Int J Gynecol Cancer 2014; 24: S5
– Koskas M., Uzan C., Gouy S., Pautier P., Lhomme C. et al.: Prognostic factors of a large retrospective series of mucinous Borderline Tumors of the Ovary (exluding peritoneal pseudomyxoma). Ann Surg Oncol 2011; 18: 40
– Kurman R.J., Carcangiu M.L., Herrington C.S. et al.: WHO Classification of Tumours of Female Reproductive Organs. Fourth Edition. WHO Classification of Tumours, Volume 6, 2014. WHO Press
– Lesieur B., Kane A., Duvillard P. et al.: Prognostic value of lymph node involvement in ovarian serous borderline tumors. Am J Obstet Gynecol 2011; 204: 438.e1
– Longacre T.A., McKenney J.K., Tazelaar H.D. et al.: Ovarian serous tumors of low malignant potential (borderline tumors): outcome-based study of 276 patients with long-term (> or = 5-year) follow-up. Am J Surg Pathol 2005; 29: 707
– Ozenne A., De Berti M., Body G. et al.: Risk factors for recurrence of Borderline ovarian tumours after conservative surgery and impact on fertility: a multicentre study by the Francogyn group. J Clin Med 2022; 11: 3645
– Skírnisdóttir I., Garmo H., Wilander E., Holmberg L.: Boderline ovarian tumors in Sweden 1960–2005: trends in incidence and age at diagnosis compared to ovarian cancer. Int J Cancer 2008; 123: 1897
– Tinelli R., Tineli A., Tinelli F.G. et al.: Conservative surgery for borderline ovarian tumors: a review. Gynecol Oncol 2006; 100: 185
– Trimble C.L., Kosary C., Trimble E.L.: Long-term survival and patterns of care in women with ovarian tumors of low malignant potential. Gynecol Oncol 2002; 86: 34
– Uzan C., Kane A., Rey A., Gouy S. et al.: Prognosis and prognostic factors if the micropapillary pattern in patients treated for stage II and III serous borderline tumors of the ovary. The Oncologist 2011; 16: 189
– Uzan C., Muller E., Kane A., Rey A. et al.: Prognostic factors for recurrence after conservative treatment in a series of 119 patients with stage I serous borderline tumors of the ovary. Ann Oncol 2014; 25: 166
– Zanetta G., Rota S., Chiari S. et al.: Behaviour of borderline tumors with particular interest to persistence, recurrence and progression to invasive carcinoma: a prospective study. J Clin Oncol 2001; 19: 2658
